BSE Live
Dec 30, 13:00Prev. Close
133.75
Open Price
133.70
Bid Price (Qty.)
132.40 (114)
Offer Price (Qty.)
132.60 (16)
NSE Live
Dec 30, 13:00Prev. Close
133.62
Open Price
133.10
Bid Price (Qty.)
132.44 (90)
Offer Price (Qty.)
132.59 (44)
| Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -312.40 | -145.43 | -245.97 | -119.04 | -69.99 | |
| Net CashFlow From Operating Activities | -210.81 | -171.91 | -182.77 | -128.04 | 44.21 | |
| Net Cash Used In Investing Activities | 155.35 | -102.19 | -104.62 | -6.61 | 13.08 | |
| Net Cash Used From Financing Activities | 55.46 | 274.25 | 224.02 | 194.25 | -50.55 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | -0.02 | -0.11 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 0.15 | -63.38 | 59.58 | 6.63 | |
| Cash And Cash Equivalents Begin of Year | 0.35 | 0.20 | 63.58 | 4.00 | 4.00 | |
| Cash And Cash Equivalents End Of Year | 0.35 | 0.35 | 0.20 | 63.58 | 10.63 |
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
17.11.2025
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.11.2025
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y